Development of a quantitative biochemical and cellular sphingomyelin synthase assay using mass spectrometry

被引:8
作者
Chen, YanQun [1 ]
Yurek, David A. [1 ]
Yu, Lan [1 ]
Wang, He [1 ]
Ehsani, Mariam E. [1 ]
Qian, Yue-Wei [1 ]
Konrad, Robert J. [1 ]
Jiang, Xian-Cheng [2 ]
Kuo, Ming-Shang [1 ]
Cao, Guoqing [1 ]
Wang, Jian [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Suny Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA
关键词
Sphingomyelin; Mass spectrometry; Assay; INCREASES; PLASMA; LIVER;
D O I
10.1016/j.ab.2013.03.016
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The last step in sphingolipid biosynthesis is the conversion of ceramide (Cer) to sphingomyelin (SM), which is catalyzed by sphingomyelin synthase (SMS). Two isoforms of SMS have been identified with differential subcellular localizations. It is not clear whether the two isoforms have any differences in biochemical or cellular SMS activities. This report describes a mass spectrometry (MS)-based method that was used to characterize biochemical and cellular SMS activities of the two isoforms of SMS, namely SMS1 and SMS2. Cellular extracts of SMSI or SMS2 expressed in SF9 cells displayed significant SMS activity. When these activities were measured by MS, both SMS1 and SMS2 demonstrated similar time- and substrate-dependent SMS activity. A previously reported SMS inhibitor, D609, inhibited both SMSI and SMS2 activity. In HEK293 cells, overexpression of either SMS1 or SMS2 significantly increased SMS activity. These studies using MS methods to measure SMS activity of SMSI and SMS2 represent the first quantitative measurement of SMS activities. The establishment of quantitative biochemical and cellular SMS assays may help to facilitate the discovery of novel SMS1- or SMS2-specific inhibitors. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 12 条
  • [1] Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice
    Dong, Jibin
    Liu, Jin
    Lou, Bin
    Li, Zhiqiang
    Ye, Xun
    Wu, Manping
    Jiang, Xian-Cheng
    [J]. JOURNAL OF LIPID RESEARCH, 2006, 47 (06) : 1307 - 1314
  • [2] Sphingomyelin synthase 2 deficiency attenuates NFκB activation
    Hailemariam, Tiruneh K.
    Huan, Chongmin
    Liu, Jing
    Li, Zhiqiang
    Roman, Christopher
    Kalbfeisch, Michael
    Bui, Hai H.
    Peake, David A.
    Kuo, Ming-Shang
    Cao, Guoqing
    Wadgaonkar, Raj
    Jiang, Xian-Cheng
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (08) : 1519 - 1526
  • [3] Identification of a family of animal sphingomyelin synthases
    Huitema, K
    van den Dikkenberg, J
    Brouwers, JFHM
    Holthuis, JCM
    [J]. EMBO JOURNAL, 2004, 23 (01) : 33 - 44
  • [4] Reducing Plasma Membrane Sphingomyelin Increases Insulin Sensitivity
    Li, Zhiqiang
    Zhang, Hongqi
    Liu, Jing
    Liang, Chien-Ping
    Li, Yan
    Li, Yue
    Teitelman, Gladys
    Beyer, Thomas
    Bui, Hai H.
    Peake, David A.
    Zhang, Youyan
    Sanders, Phillip E.
    Kuo, Ming-Shang
    Park, Tae-Sik
    Cao, Guoqing
    Jiang, Xian-Cheng
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (20) : 4205 - 4218
  • [5] Sphingomyelin Synthase 2 Is One of the Determinants for Plasma and Liver Sphingomyelin Levels in Mice
    Liu, Jing
    Zhang, Hongqi
    Li, Zhiqiang
    Hailemariam, Tiruneh K.
    Chakraborty, Mahua
    Jiang, Kailiu
    Qiu, Daniel
    Bui, Hai H.
    Peake, David A.
    Kuo, Ming-Shang
    Wadgaonkar, Raj
    Cao, Guoqing
    Jiang, Xian-Cheng
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (06) : 850 - U189
  • [6] Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation - Does sphingomyelin synthase account for the putative, phosphatidylcholine-specific phospholipase C?
    Luberto, C
    Hannun, YA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) : 14550 - 14559
  • [7] Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells
    Meng, AM
    Luberto, C
    Meier, P
    Bai, AP
    Yang, XF
    Hannun, YA
    Zhou, DH
    [J]. EXPERIMENTAL CELL RESEARCH, 2004, 292 (02) : 385 - 392
  • [8] Dynamic Modification of Sphingomyelin in Lipid Microdomains Controls Development of Obesity, Fatty Liver, and Type 2 Diabetes
    Mitsutake, Susumu
    Zama, Kota
    Yokota, Hazuki
    Yoshida, Tetsuya
    Tanaka, Miki
    Mitsui, Masaru
    Ikawa, Masahito
    Okabe, Masaru
    Tanaka, Yoshikazu
    Yamashita, Tadashi
    Takemoto, Hiroshi
    Okazaki, Toshiro
    Watanabe, Ken
    Igarashi, Yasuyuki
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (32) : 28544 - 28555
  • [9] Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells
    Tafesse, Fikadu Geta
    Huitema, Klazien
    Hermansson, Martin
    van der Poel, Selene
    van den Dikkenberg, Joep
    Uphoff, Andreas
    Somerharju, Pentti
    Holthuis, Joost C. M.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (24) : 17537 - 17547
  • [10] The multigenic sphingomyelin synthase family
    Tafesse, Fikadu Geta
    Ternes, Philipp
    Holthuis, Joost C. M.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (40) : 29421 - 29425